Guillain-Barré Syndrome (GBS) is a rare neurological condition that causes muscle weakness and can lead to paralysis. Linked ...

Alzheimer's disease Therapeutics Market. LAS VEGAS, NV, UNITED STATES, January 23, 2025 /EINPresswire / -- DelveInsight's“Acute Respiratory Distress Synd ...

InflaRx receives European marketing authorization for Gohibicto treat of SARS-CoV-2-induced acute respiratory distress syndrome: Jena, Germany Friday, January 17, 2025, 11:00 Hrs ...

InflaRx N.V. IFRX shares gained 7.7% on Wednesday following the European Commission's (EC) approval of marketing ...

The European Commission (EC) has granted marketing authorisation under exceptional circumstances for InflaRx’s Gohibic ...

H.C. Wainwright analyst Edward White reiterated a Buy rating on InflaRx (IFRX – Research Report) today and set a price target of $8.00.Stay ...

InflaRx (IFRX) announced that the European Commission has granted marketing authorization under exceptional circumstances for Gohibic for the ...

The exosome therapies market is expected to experience significant growth due to increased interest in regenerative medicine, cancer treatments, and drug delivery systems. Leading Indications ...

Recent research paper by Fernando C. Barros and colleagues from the INTERCOVID-2022 study focused on the impact of COVID-19 ...

Clinical signs of H5N1 Bird Flu in cattle include reduced feed consumption, a marked drop in milk production—sometimes resulting in thick, colostrum-like milk or no milk production at all—respiratory ...

China is experiencing a rise in respiratory illnesses, particularly HMPV, as winter approaches. Hospitals are overwhelmed, with fears of a healthcare crisis. A seasonal rise in respiratory ...